Related Experiment Video
Updated: Jul 14, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Celiac disease: caught between a rock and a hard place
1Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, The Netherlands. f.koning@lumc.nl
Celiac disease (CD) involves an immune response to gluten, triggered by specific HLA-DQ molecules binding gluten peptides. This leads to both adaptive and innate immune responses causing intestinal damage.
Area of Science:
- Immunology
- Gastroenterology
- Genetics
Background:
- Celiac disease (CD) is an intestinal disorder characterized by gluten intolerance.
- CD is strongly associated with specific human leukocyte antigen (HLA) variants, namely HLA-DQ2 and HLA-DQ8.
Purpose of the Study:
- To elucidate the mechanisms by which gluten peptides trigger immune responses in celiac disease.
- To understand the roles of both adaptive and innate immunity in gluten-induced intestinal damage.
Main Methods:
- Analysis of HLA-DQ binding to enzymatically modified gluten peptides.
- Investigation of T-cell responses to HLA-DQ peptide complexes.
- Assessment of gluten-induced innate immune activation.
Main Results:
- Disease-predisposing HLA-DQ2 and HLA-DQ8 molecules bind specific gluten peptides.
- These complexes elicit inflammatory T-cell responses in the small intestine.
- Gluten also activates innate immune responses contributing to tissue damage.
Conclusions:
- Celiac disease pathogenesis involves a dual immune attack: adaptive and innate responses to gluten.
- Understanding these mechanisms offers insights for developing novel celiac disease treatments.
- Findings may inform research on other multifactorial and autoimmune diseases.
Related Concept Videos
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Gastritis II: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease

